Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Study of SP-103 in Healthy Adults
NCT04819581Phase 1Completed
- Sponsor
- Scilex Holding
- Start
- Aug 2019
- Primary completion
- Aug 2019
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of SP-103 in acute low back pain (4 arms), sponsored by Scilex Holding. Primary endpoints: Peak Plasma Concentration, Area Under the Curve 0-48h and 1 more. Started Aug 2019; status: completed.
02
Drugs
SP-103
03
Conditions
acute low back pain
Beyond the preview
Go deeper on NCT04819581.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04819581.